Clinical trial

Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive…

NCT00452803 · National Cancer Center, Korea, Other · Unknown status

Key facts

NCT number NCT00452803
Title Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)
Official title A Randomized Phase II Study Preoperative Chemotherapy Versus Preoperative Concurrent Chemoradiotherapy for Patients With Biopsy-Proven N2 Stage IIIA Non-Small Cell Lung Cancer
Lead sponsor National Cancer Center, Korea, Other
Status Unknown status
Phase Phase 2
Study type Interventional
Conditions Lung Cancer
Intervention type Drug, Radiation
Interventions chemotherapy, Concurrent chemoradiation therapy
Enrollment 102
Start date Apr 1, 2006
Primary completion Dec 1, 2011
Completion Dec 1, 2012
First posted Mar 28, 2007
Last update posted Jul 12, 2010
Countries South Korea

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 FDA inspections linked to this trial
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies